Germany-based Sanner officially opened its first U.S.-based production facility in Greensboro, NC, just weeks after commencing initial operations.
The event marks a strategic milestone in the company’s 134-year history, signaling a new era of innovation, customer proximity, and sustainable growth with localized production to better serve MedTech and pharmaceutical partners across North America, according to Christian Classen.
“This is more than just a new facility,” said Classen. “It’s a bold step forward in our global journey, reinforcing our long-term commitment to supporting our customers in North America with local production, cutting-edge technology, and service.”
Key highlights of the new facility include a 60,500-sq-ft site equipped with GMP-certified cleanrooms (ISO class 7 & 8), advanced injection molding, high-speed desiccant filling, strong laboratory capabilities, and a facility designed for the future with 20,000-sq-ft of expansion space built into the site. Sanner’s investment in Greensboro reinforces its position as a supplier of primary packaging and as a CDMO for the healthcare industry, added Classen.
By combining design expertise with Gilero, as Sanner Group’s Design Center of Excellence in the U.S., local, and global manufacturing capacity, regulatory insight, and operations, Sanner helps its partners to not only navigate these challenges but to thrive within them, continued Classen.
Whether launching a next-generation drug delivery combination device, an innovative diagnostic, a connected health device, or a pharmaceutical packaging to maintain physical and chemical stability, “Sanner provides everything pharmaceutical companies need from a single source,” said Classen, emphasizing that with recent expansions in Germany, China, and now the U.S., the company is well-positioned to support the evolving needs of healthcare customers around the world to bring innovative solutions closer to where they’re needed most.
The post Sanner Officially Opens Its First Production Facility in the U.S. appeared first on GEN – Genetic Engineering and Biotechnology News.
